Randomised studies in acute myeloid leukaemia: the double truth
- 1 March 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (5), 471-472
- https://doi.org/10.1038/sj.bmt.1702199
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Transplantation in First Remission of Acute Myeloid LeukemiaNew England Journal of Medicine, 1998
- Autologous Stem Cell Transplantation in Acute Myelocytic LeukemiaBlood, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- Randomized Comparison of DAT Versus ADE as Induction Chemotherapy in Children and Younger Adults With Acute Myeloid Leukemia. Results of the Medical Research Council's 10th AML Trial (MRC AML10)Blood, 1997
- A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]Blood, 1996
- Post-Remission Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994